Showing results (651-660 of 1,271) with videos related to

Sort By:
Pageof 128
Psychopharmacology Bulletin|August 23, 2021
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive DisorderKumar Rakesh, Sharma Arvind, Bansal Pir Dutt, et al.
Psychopharmacology Bulletin|August 23, 2021
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a PrimerSagar V Parikh, Daniela Lopez, Jennifer L Vande Voort, et al.
Psychopharmacology Bulletin|August 23, 2021
MDMA to Treat PTSD in AdultsDustin Latimer, Michael D Stocker, Kia Sayers, et al.
Psychopharmacology Bulletin|June 9, 2020
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom SeverityKeming Gao, Jodi G Arnold, Thomas J Prihoda, et al.
Psychopharmacology Bulletin|January 1, 1992
Fluoxetine for trichotillomania: an open clinical trialL M Koran, A Ringold, W Hewlett
Psychopharmacology Bulletin|January 1, 1992
Haloperidol in schizophrenic children: early findings from a study in progressE K Spencer, V Kafantaris, M V Padron-Gayol, et al.
Psychopharmacology Bulletin|January 1, 1992
Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot studyV Kafantaris, M Campbell, M V Padron-Gayol, et al.
Psychopharmacology Bulletin|January 1, 1991
Does sigma receptor antagonism predict clinical antipsychotic efficacy?R L Borison, B I Diamond, A T Dren
Psychopharmacology Bulletin|January 1, 1991
Repeated episodes of neuroleptic-related dyskinesias in autistic childrenR P Malone, M Ernst, K A Godfrey, et al.
Psychopharmacology Bulletin|January 1, 1991
The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorderJ C Ballenger, S McDonald, R Noyes, et al.
Pageof 128